Mark N. Gaze
University College London Hospitals NHS Foundation Trust(GB)Great Ormond Street Hospital for Children NHS Foundation Trust(GB)Royal London Hospital(GB)University College London(GB)
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Glioma Diagnosis and Treatment, Advanced Radiotherapy Techniques, Cancer, Hypoxia, and Metabolism, Neuroendocrine Tumor Research Advances
Most-Cited Works
- → Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial(2018)383 cited
- → Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial(2017)339 cited
- → Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules(1997)282 cited
- → Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial(2018)182 cited
- → 177Lu-DOTATATE Molecular Radiotherapy for Childhood Neuroblastoma(2011)162 cited
- →